Mutual Fund Ownership
Ownership as on: Thu, 28 Mar, 2024

Tata Small Cap Fund Regular Growth

3/5
Equity
Amount Invested (Cr.)89.56
% of AUM1.42%

ICICI Prudential Nifty Pharma Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)0.57
% of AUM1.42%

Mahindra Manulife Large Cap Fund Regular Growth

2/5
Equity
Amount Invested (Cr.)5.28
% of AUM1.39%

Mirae Asset Midcap Fund Regular Growth

3/5
Equity
Amount Invested (Cr.)111.36
% of AUM1.27%

Mahindra Manulife Aggressive Hybrid Fund Regular Growth

4/5
Hybrid
Amount Invested (Cr.)10.86
% of AUM1.05%

FAQs about Natco Pharma share price

Natco Pharma is trading at 958.70 as on Thu Mar 28 2024 07:57:13. This is -1.37% lower as compared to its previous closing price of 972.00.

The market capitalization of Natco Pharma is 17171.26 Cr as on Thu Mar 28 2024 07:57:13.

The average broker rating on Natco Pharma is Buy. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 5 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 1 analysts have given a strong sell rating

The 52 wk high for Natco Pharma is 1107.85 whereas the 52 wk low is 522.15

Natco Pharma can be analyzed on the following key metrics -

  • TTM P/E: 11.45
  • Sector P/E: 31.33
  • Dividend Yield: 0.98%
  • D/E ratio: -

Natco Pharma reported a net profit of 715.30 Cr in 2023.

Recommended For You
Images
Trending Stocks
1,647.80+66.60(4.21%)
7,245.75+222.55(3.17%)
1,051.50-2.10 (-0.20%)